| Pharmaceutical Information |
| Drug Name |
Phenoxybenzamine |
| Drug ID |
BADD_D01754 |
| Description |
An alpha-adrenergic antagonist with long duration of action. It has been used to treat hypertension and as a peripheral vasodilator. |
| Indications and Usage |
For the treatment of phaeochromocytoma (malignant), benign prostatic hypertrophy and malignant essential hypertension. |
| Marketing Status |
Prescription |
| ATC Code |
C04AX02 |
| DrugBank ID |
DB00925
|
| KEGG ID |
D08358
|
| MeSH ID |
D010643
|
| PubChem ID |
4768
|
| TTD Drug ID |
D0X2DK
|
| NDC Product Code |
69988-0016 |
| Synonyms |
Phenoxybenzamine | Phenoxybenzamine Hydrochloride | Hydrochloride, Phenoxybenzamine | Dibenzyline | Dibenzylin | Dibenyline | Dibenylene | Dibenziran | Dibenzyran |
|
| Chemical Information |
| Molecular Formula |
C18H22ClNO |
| CAS Registry Number |
59-96-1 |
| SMILES |
CC(COC1=CC=CC=C1)N(CCCl)CC2=CC=CC=C2 |
| Chemical Structure |
|
|
| ADR Related Proteins Induced by Drug |
| ADR Term |
Protein Name |
UniProt AC |
TTD Target ID |
PMID |
| Not Available | Not Available | Not Available | Not Available | Not Available |
|
| ADRs Induced by Drug |
|
|
